Phathom Pharmaceuticals (PHAT) FCF Margin (2023 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly FCF Margin came in at 26.94% in Q1 2026, up 27086.0% year-on-year from N/an in Q1 2025, and down 151.29% on a QoQ basis from 10.72% in Q4 2025.
Phathom Pharmaceuticals (PHAT) FCF Margin (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 4 years of FCF Margin data on file, last reported at 26.94% in Q1 2026.
- On a quarterly basis, FCF Margin rose 27086.0% year-over-year to 26.94% in Q1 2026; TTM through Mar 2026 was 48.21%, a 29708.0% increase from a year earlier, with the FY2025 full-year figure at 95.94%, up 38690.0% from the prior year.
- FCF Margin for Q1 2026 stood at 26.94%, down from 10.72% in the prior quarter.
- Over the last five years, FCF Margin for PHAT reached as high as 10.72% in Q4 2025 and fell as low as 6120.38% in Q4 2023.
- Historically, FCF Margin has averaged 1182.35% across 4 years, with a median of 255.65% in 2024.
- Across the five-year window, FCF Margin surged 590688 bps in 2024 and surged 20278 bps in 2025, its largest moves.
- Year by year, FCF Margin stood at 6120.38% in 2023, then jumped by 97 bps to 213.5% in 2024, then jumped by 95 bps to 10.72% in 2025, then tumbled by 151 bps to 26.94% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 26.94% in Q1 2026, 10.72% in Q4 2025, and 28.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 945.22 Mn | 761.46 Mn | 46.31 Mn | -26.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.94% |
| Dec 31, 2025 | -10.72% |
| Sep 30, 2025 | -28.38% |
| Jun 30, 2025 | -159.09% |
| Mar 31, 2025 | -297.80% |
| Dec 31, 2024 | -213.50% |
| Sep 30, 2024 | -389.51% |
| Jun 30, 2024 | -965.20% |
| Mar 31, 2024 | -3,611.92% |
| Dec 31, 2023 | -6,120.38% |